期刊文献+

氨基酸类凝胶因子的合成及其性质考察 被引量:4

Synthesis and characterization of amino acid derivatives gelator
下载PDF
导出
摘要 目的合成并表征氨基酸类凝胶因子,探讨其在植物油中的胶凝能力。方法以l-丙氨酸甲酯盐酸盐、l-丙氨酸乙酯盐酸盐和月桂酰氯为原料,合成月桂酰-丙氨酸甲酯(LAM)凝胶因子及月桂酰-丙氨酸乙酯(LAE)凝胶因子,采用IR、1H-NMR、MS对其结构进行表征,并对其熔点、热稳定性、在各种植物油中的最小胶凝质量浓度、相转变温度等基本性质进行了研究。结果成功合成了LAM及LAE,并对其结构进行了表征,LAM和LAE的熔点分别为59.0℃和46.3℃;在100℃时均能保持稳定状态;LAM的最小胶凝质量浓度为43.1 g.L-1,LAE的最小胶凝质量浓度为100.3 g.L-1,LAM的胶凝能力强于LAE。结论LAM在一级大豆油中的胶凝能力很强,是一种良好的凝胶因子及植入剂控释辅料。 Objective To synthesize and identify gelators of amino acid derivatives and investigate their gelling ability in some kinds of vegetable oil.Methods Gelators of N-lauroyl-l-alanine methyl ester(LAM)and N-lauroyl-l-alanine ethyl ester(LAE)were synthesized with l-alanine methyl ester,l-alanine ethyl ester and lauroyl chloride as materials.The structural characteristics of gelators were identified by means of IR,^1H-NMR,and MS.Melting point,thermostability,minimal gelling concentration of gelator and temperature of phase transition were investigated.Results LAM and LAE were synthesized,the melting point of LAM and LAE were 59.0 ℃ and 46.3 ℃,respectively.They were thermostable under 100 ℃.Gelling ability of LAM was stronger than LAE,and the minimal gelling concentration of LAM and LAE were 43.1 g·L^-1 and 100.3 g·L^-1,respectively.Conclusions The gelling ability of LAM is very well.It is a good gelator and control release pharmaceutical excipient.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第1期28-33,共6页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(30772670)
关键词 凝胶因子 热稳定性 倒流法 最小胶凝浓度 相转变温度 gelator thermostability inverse flow method minimal gelling concentration phase transition temperature
  • 相关文献

参考文献7

  • 1杨亚江,崔文瑾.能使有机溶剂凝胶化的凝胶因子研究进展[J].有机化学,2001,21(9):632-639. 被引量:28
  • 2AUDE M, MICHEL L, ANNE-CLAUDE C H, et al. Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants [ J]. Biomaterials,2005,26 : 6242 - 6253.
  • 3ABDALLAH D J, WEISS R G. Organogels and low molecular mass organic gelators [ J ]. Adv Mater,2000, 12 : 1237 - 1247.
  • 4ANDA V, JEAN-CHRISTOPHE L. Organogels and their use in drug delivery-A review [ J ]. Journal of Conlzolled Release,2008,125 : 179 - 192.
  • 5MADER K,BITTNER B ,LI You-xin,et al. Monitoring microviscosity and micmacidity of the albumin microenvironment inside degrading microparticles from poly ( lactide-co-glycollide ) ( PLG ) or ABA-triblock polymers containing hydrophobic poly ( lactide-co-glycollide) A blocks and hydrophilic poly (ethyleneoxide) blocks [ J ]. Pharm Res, 1998,15:787 - 793.
  • 6董吉,蒋曙光,平其能.注射型原位凝胶植入剂的研究进展[J].药学进展,2007,31(3):109-113. 被引量:21
  • 7KAZUHIRO Y, YUSUKE T, NORIHIRO M, et al. Self-assembly of carbazole-containing gelators: alignment of the chromospheres in fibrous aggregates [ J ]. Tetrahedron,2007,63:7358 - 7365.

二级参考文献23

  • 1Lu L,Langmuir,1995年,11卷,3630页
  • 2Lin Y C,Macromolecules,1987年,20卷,414页
  • 3Wang L,Venkatraman S,Kleiner L.Drug release from injectable depots:two different in vitro mechanisms[J].J Controlled Release,2004,99 (2):207-216.
  • 4Astaneh R,Moghimi H R,Erfan M,et al.Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behavior[J].Daru,2006,14(2):65-70.
  • 5Brodbeck K J,DesNoyer J R,McHugh A J.Phase inversion dynamics of PLGA solutions related to drug delivery,part Ⅱ.The role of solution thermodynamic and bath side mass transfer[J].J Controlled Release,1999,62(3):333-334.
  • 6Graham P D,Brodbeck K J,McHugh A J.Phase inversion dynamics of PLGA solutions related to drug delivery[J].J Controlled Release,1999,58(2):233-245.
  • 7Lambert W J,Peck K D.Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins[J].J Controlled Release,1995,33(1):189-195.
  • 8Bakhshi R,Vasheghani-Farahani E,Mobedi H et al.The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant[J].Poly Adv Technol,2006,17(5):354-359.
  • 9Chandrashekar B L,Zhou M X,Jarr E M.Controlled release liquid delivery compositions with low initial drug burst:US,6630155[P].2003-10-07.
  • 10Kang F,Singh J.In vitro release of insulin and biocompatibility of in situ forming gel systems[J].Int J Pharm,2005,304(1-2):83-90.

共引文献47

同被引文献25

  • 1殷晓,王大鹏,金屾,贾亮,王传胜.氨基酸衍生物有机凝胶的X射线衍射行为研究[J].辽宁大学学报(自然科学版),2013,40(3):237-242. 被引量:2
  • 2Hirst A R, Escuder B, Miravet J F, et al. High-tech applications of self-assembling supramolecular nanostructured gel-phase materials: from regenerative medicine to electronic devices [ J 1. Angew Chem Int Ed Engl, 2008,47(42) : 8002 -8018.
  • 3Adams D J. Dipeptide and tripeptide conjugates as low-molecular- weight hydrogelators[ J]. Macromol Biosci, 2011, 11 (2) : 160 - 173.
  • 4Hirst A R, Coates I A, Bouchetean T R, et al. Low-molecular-weight gelators : elucidating the principles of gelation based on gelator solubili- ty and a cooperative self-assembly model[ J ]. J Am Chem Soc, 2008, 130(28) : 9113 -9121.
  • 5Samanta S K, Pal A, Bhattacharya S. Choice of the end functional groups in tri(p-phenylenevinylene) derivatives controls its physical ge- lation abilities [ J ]. Langmuir, 2009, 25 ( 15 ) : 8567 - 8578.
  • 6Hirst A R, Smith D K. Dendritic Gelators [ J ]. Top Curr Chem, 2005, 256 : 237 - 273.
  • 7Fages F, Vogtle F, Zinic M. Systematic design of amide- and urea-type gelators with tailored properties[J]. Top Curr Chem, 2005, 256: 77 - 131.
  • 8Luboradzki R, Gronwald O, Ikeda M, et al. An attempt to predict thegelation ability of hydrogen-bond-based gelators utilizing a glycoside li- brary[ J ]. Tetrahedron, 2000, 56 (49) : 9595 - 9599.
  • 9Abdallah D J, Weiss R G.Organogels and low molecular mass organic gelators[J].Adv Mater, 2000, 12:237-247.
  • 10Sangeeth N M, Maitra U.Supramolecular gels:Functions and uses[J].Chem Soc Rev, 2005, 34:821-836.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部